Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Assessing the potential of photogrammetry to monitor feed intake of dairy cows.

Bloch V, Levit H, Halachmi I.

J Dairy Res. 2019 Feb;86(1):34-39. doi: 10.1017/S0022029918000882. Epub 2019 Feb 18.

PMID:
30773145
2.

Opinion of health professionals and drug users before the forthcoming opening of the first drug consumption room in Paris: a quantitative cross-sectional study.

Cleirec G, Fortias M, Bloch V, Clergue-Duval V, Bellivier F, Dusouchet T, Debaulieu C, Vorspan F.

Harm Reduct J. 2018 Oct 25;15(1):53. doi: 10.1186/s12954-018-0260-8.

3.

[Securing the distribution of patient-specific unit dose medication following the installation of a unit dose dispensing system: Cartography of risks a priori within a hospital pharmacy].

Martinez L, Bloch V, Jacob A, Iskra F, Barreteau H, Razurel A.

Ann Pharm Fr. 2018 Nov;76(6):473-488. doi: 10.1016/j.pharma.2018.05.004. Epub 2018 Sep 19. French.

PMID:
30243472
4.

Gender-specific study of recurrent suicide attempts in outpatients with multiple substance use disorders.

Icick R, Vorspan F, Karsinti E, Ksouda K, Lépine JP, Brousse G, Mouly S, Bellivier F, Bloch V.

J Affect Disord. 2018 Dec 1;241:546-553. doi: 10.1016/j.jad.2018.08.076. Epub 2018 Aug 13.

PMID:
30153638
5.

QT length during methadone maintenance treatment: gene × dose interaction.

Zerdazi EH, Vorspan F, Marees AT, Naccache F, Lepine JP, Laplanche JL, Prince N, Marie-Claire C, Bellivier F, Mouly S, Bloch V.

Fundam Clin Pharmacol. 2019 Feb;33(1):96-106. doi: 10.1111/fcp.12405.

PMID:
30086202
6.

A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population.

Vallet T, Belissa E, Laribe-Caget S, Chevallier A, Chedhomme FX, Leglise P, Piccoli M, Michelon H, Bloch V, Meaume S, Grancher AS, Bachalat N, Boulaich I, Abdallah F, Rabus M, Rwabihama JP, Ribemont AC, Lachuer C, Perquy I, Lechowski L, Delahaye A, Depoisson M, Orven Y, Guinot C, Gibaud S, Michel C, Mahiou A, Belbachir SA, Trouvin JH, Dufaÿ-Wojcicki A, Boudy V, Ruiz F.

Pharm Res. 2018 May 7;35(7):136. doi: 10.1007/s11095-018-2424-3.

7.

[Temporary approval for intranasal naloxone: Setting up in a French addiction center].

Barré T, Vorspan F, Fortias M, Veyrier M, Cavagna P, Azuar J, Nicolas L, Naccache F, Barreteau H, Bellivier F, Bloch V.

Therapie. 2018 Dec;73(6):495-500. doi: 10.1016/j.therap.2018.03.003. Epub 2018 Mar 29. French.

PMID:
29680374
8.

Relevance of treated cocaine users' retrospective memory of first cocaine use.

Karsinti E, Piani K, Zerdazi EH, Maskos U, Faure P, Romo L, Bellivier F, Brousse G, Lépine JP, Bloch V, Vorspan F.

Psychiatry Res. 2018 Jun;264:210-216. doi: 10.1016/j.psychres.2018.03.058. Epub 2018 Mar 29.

PMID:
29653350
9.

An observational study of benzodiazepine prescription during inpatient alcohol detoxification for patients with vs. without chronic pretreatment with high-dosage baclofen.

Martinez L, Vorspan F, Declèves X, Azuar J, Fortias M, Questel F, Dereux A, Grichy L, Barreteau H, Bellivier F, Lépine JP, Bloch V.

Fundam Clin Pharmacol. 2018 Apr;32(2):200-205. doi: 10.1111/fcp.12339. Epub 2018 Jan 11.

PMID:
29224234
10.

Population pharmacokinetics of oral baclofen at steady-state in alcoholic-dependent adult patients.

Chevillard L, Sabo N, Tod M, Labat L, Chasport C, Chevaleyre C, Thibaut F, Barré J, Azuar J, Questel F, Vorspan F, Bloch V, Bellivier F, Granger B, Barrault C, Declèves X.

Fundam Clin Pharmacol. 2018 Apr;32(2):239-248. doi: 10.1111/fcp.12330. Epub 2017 Nov 23.

PMID:
29091319
11.

Serious suicide attempts in outpatients with multiple substance use disorders.

Icick R, Karsinti E, Lépine JP, Bloch V, Brousse G, Bellivier F, Vorspan F.

Drug Alcohol Depend. 2017 Dec 1;181:63-70. doi: 10.1016/j.drugalcdep.2017.08.037. Epub 2017 Sep 23.

PMID:
29035706
12.

Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.

Marie-Claire C, Jourdaine C, Lépine JP, Bellivier F, Bloch V, Vorspan F.

Pharmacogenomics. 2017 Sep;18(14):1359-1372. doi: 10.2217/pgs-2017-0040. Epub 2017 Aug 25. Review.

PMID:
28841113
13.

Anxiety disorders are associated with early onset of heroin use and rapid transition to dependence in methadone maintained patients.

Karsinti E, Fortias M, Dupuy G, Ksouda K, Laqueille X, Simonpoli AM, Touzeau D, Avril E, Orizet C, Belforte B, Coeuru P, Polomeni P, Icick R, Jarroir M, Bloch V, Scott J, Lépine JP, Bellivier F, Vorspan F.

Psychiatry Res. 2016 Nov 30;245:423-426. doi: 10.1016/j.psychres.2016.04.064. Epub 2016 Jul 19.

PMID:
27620325
14.

Variability of response to methadone: genome-wide DNA methylation analysis in two independent cohorts.

Marie-Claire C, Crettol S, Cagnard N, Bloch V, Mouly S, Laplanche JL, Bellivier F, Lepine JP, Eap C, Vorspan F.

Epigenomics. 2016 Feb;8(2):181-95. doi: 10.2217/epi.15.110. Epub 2016 Jan 21.

PMID:
26792095
15.

Self-reported cue-induced physical symptoms of craving as an indicator of cocaine dependence.

Vorspan F, Fortias M, Zerdazi el-H, Karsinti E, Bloch V, Lépine JP, Bellivier F, Brousse G, van den Brink W, Derks EM.

Am J Addict. 2015 Dec;24(8):740-3. doi: 10.1111/ajad.12303. Epub 2015 Nov 6.

PMID:
26541796
16.

A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients.

Icick R, Peoc'h K, Karsinti E, Ksouda K, Hajj A, Bloch V, Prince N, Mouly S, Bellivier F, Lépine JP, Laplanche JL, Vorspan F.

Am J Addict. 2015 Oct;24(7):613-20. doi: 10.1111/ajad.12273. Epub 2015 Sep 1.

PMID:
26331953
17.

Childhood trauma are not associated with the intensity of transient cocaine induced psychotic symptoms.

Karsinti E, Jarroir M, Zerdazi el-H, Bloch V, Dupuy G, Belforte B, Coeuru P, Plat A, Deschenau A, Cottencin O, Gay A, Lack P, Pelissier-Alicot AL, Bellivier F, Lépine JP, Brousse G, Vorspan F.

Psychiatry Res. 2015 Aug 30;228(3):941-4. doi: 10.1016/j.psychres.2015.05.065. Epub 2015 Jun 27.

PMID:
26154812
18.

Anxiety and substance use disorders: co-occurrence and clinical issues.

Vorspan F, Mehtelli W, Dupuy G, Bloch V, Lépine JP.

Curr Psychiatry Rep. 2015 Feb;17(2):4. doi: 10.1007/s11920-014-0544-y. Review.

PMID:
25617040
19.

Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.

Mouly S, Bloch V, Peoc'h K, Houze P, Labat L, Ksouda K, Simoneau G, Declèves X, Bergmann JF, Scherrmann JM, Laplanche JL, Lepine JP, Vorspan F.

Br J Clin Pharmacol. 2015 Jun;79(6):967-77. doi: 10.1111/bcp.12576.

20.

Are empty methadone bottles empty? An analytic study.

Dupuy G, Cavalcanti L, Bourgogne E, Brichant-Petitjean C, Gomberoff L, Bloch V, Bellivier F, Lépine JP, Laprévote O, Vorspan F.

Harm Reduct J. 2014 Jul 2;11:20. doi: 10.1186/1477-7517-11-20.

21.

KCNH2 polymorphism and methadone dosage interact to enhance QT duration.

Hajj A, Ksouda K, Peoc'h K, Curis E, Messali A, Deveaux LL, Bloch V, Prince N, Mouly S, Scherrmann JM, Lépine JP, Laplanche JL, Drici MD, Vorspan F.

Drug Alcohol Depend. 2014 Aug 1;141:34-8. doi: 10.1016/j.drugalcdep.2014.04.027. Epub 2014 May 14.

PMID:
24875677
22.

OPRM1 polymorphism and lifetime suicide attempts among stabilized, methadone-maintained outpatients.

Icick R, Peoc'h K, Ksouda K, Bloch V, Laplanche JL, Lépine JP, Bellivier F, Vorspan F.

Psychiatry Res. 2014 Aug 15;218(1-2):259-60. doi: 10.1016/j.psychres.2014.04.035. Epub 2014 Apr 24. No abstract available.

PMID:
24813900
23.

Transient cocaine-induced chest pain: a case series.

Delchev Y, Fortias M, Dupuy G, Orizet C, Bloch V, Puymirat E, Bellivier F, Lépine JP, Vorspan F.

J Addict Med. 2014 Mar-Apr;8(2):111-5. doi: 10.1097/ADM.0000000000000016.

PMID:
24503926
24.

A life-threatening dichlorophen poisoning case: clinical features and kinetics study.

Langrand J, Moesch C, Le Grand R, Bloch V, Garnier R, Baud FJ, Megarbane B.

Clin Toxicol (Phila). 2013 Mar;51(3):178-81. doi: 10.3109/15563650.2013.776069.

PMID:
23473463
25.

The Obsessive-Compulsive Cocaine Scale (OCCS): a pilot study of a new questionnaire for assessing cocaine craving.

Vorspan F, Bellais L, Romo L, Bloch V, Neira R, Lépine JP.

Am J Addict. 2012 Jul-Aug;21(4):313-9. doi: 10.1111/j.1521-0391.2012.00248.x. Epub 2012 May 16.

PMID:
22691009
26.

[When and how to detoxify clients from methadone maintenance treatment?].

Ksouda K, Bloch V, Dugarin J, Dupuy G, Laqueille X, Lépine JP, Vorspan F.

Presse Med. 2013 Jan;42(1):e28-36. doi: 10.1016/j.lpm.2012.04.011. Epub 2012 May 28. Review. French.

PMID:
22647623
27.

Cocaine-induced psychotic symptoms in French cocaine addicts.

Vorspan F, Brousse G, Bloch V, Bellais L, Romo L, Guillem E, Coeuru P, Lépine JP.

Psychiatry Res. 2012 Dec 30;200(2-3):1074-6. doi: 10.1016/j.psychres.2012.04.008. Epub 2012 May 1.

PMID:
22551940
28.

[Stable iodine as a prophylaxis therapy following exposure to radioactive iodines: pharmacological and pharmaceutical characteristics].

Hosten B, Rizzo-Padoin N, Scherrmann JM, Bloch V.

Ann Pharm Fr. 2012 Mar;70(2):75-81. doi: 10.1016/j.pharma.2012.01.003. Epub 2012 Feb 28. Review. French.

PMID:
22500958
29.

Prospective assessment of transient cocaine-induced psychotic symptoms in a clinical setting.

Vorspan F, Bloch V, Brousse G, Bellais L, Gascon J, Lépine JP.

Am J Addict. 2011 Nov-Dec;20(6):535-7. doi: 10.1111/j.1521-0391.2011.00181.x. Epub 2011 Oct 4.

PMID:
21999499
30.

[Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence].

Vorspan F, Guillem E, Bloch V, Bellais L, Sicot R, Noble F, Lepine JP, Gorelick DA.

Encephale. 2011 Sep;37(4):266-72. doi: 10.1016/j.encep.2010.12.007. Epub 2011 Feb 5. French.

PMID:
21981886
31.

Epinephrine requirement based on the reported ingested dose in chloroquine poisoning: usefulness and limitations of dose-effect modelling.

Megarbane B, Hirt D, Bloch V, Baud FJ.

Clin Toxicol (Phila). 2011 Mar;49(3):193-4. doi: 10.3109/15563650.2011.563746. No abstract available.

PMID:
21495891
32.

Blood concentrations are better predictors of chioroquine poisoning severity than plasma concentrations: a prospective study with modeling of the concentration/effect relationships.

Mégarbane B, Bloch V, Hirt D, Debray M, Résiére D, Deye N, Baud FJ.

Clin Toxicol (Phila). 2010 Nov;48(9):904-15. doi: 10.3109/15563650.2010.518969. Epub 2010 Nov 17.

PMID:
21080867
33.

Could the inter-individual variability in cocaine-induced psychotic effects influence the development of cocaine addiction? Towards a new pharmacogenetic approach to addictions.

Brousse G, Vorspan F, Ksouda K, Bloch V, Peoc'h K, Laplanche JL, Mouly S, Schmidt J, Llorca PM, Lepine JP.

Med Hypotheses. 2010 Dec;75(6):600-4. doi: 10.1016/j.mehy.2010.07.043.

PMID:
20801583
34.

A case report of transient but clinically relevant interaction between methadone and duloxetine: a reply to McCance-Katz et al.

Vorspan F, Ksouda K, Bloch V, Laplanche JL, Peoc'h K, Hajj A, Scherrmann JM, Mouly S, Lépine JP.

Am J Addict. 2010 Sep-Oct;19(5):458-9. doi: 10.1111/j.1521-0391.2010.00062.x. No abstract available.

PMID:
20716309
35.

Grid-based International Network for Flu observation (g-INFO).

Doan TT, Bernard A, Da-Costa AL, Bloch V, Le TH, Legre Y, Maigne L, Salzemann J, Sarramia D, Nguyen HQ, Breton V.

Stud Health Technol Inform. 2010;159:215-26.

PMID:
20543440
36.

Self-reported sleep disturbances during cannabis withdrawal in cannabis-dependent outpatients with and without opioid dependence.

Vorspan F, Guillem E, Bloch V, Bellais L, Sicot R, Noble F, Lepine JP, Gorelick DA.

Sleep Med. 2010 May;11(5):499-500. doi: 10.1016/j.sleep.2009.12.001. Epub 2010 Feb 6. No abstract available.

37.

Blood cocaine and metabolite pharmacokinetics after cardiac arrest in a body-packer case.

de Prost N, Mégarbane B, Questel F, Bloch V, Bertaux DC, Pourriat JL, Rabbat A.

Hum Exp Toxicol. 2010 Jan;29(1):49-53. doi: 10.1177/0960327109354940. Epub 2009 Nov 19.

PMID:
19933255
38.

Smoking ban in a psychiatry department: are nonsmoking employees less exposed to environmental tobacco smoke?

Vorspan F, Bloch V, Guillem E, Dupuy G, Pirnay S, Jacob N, Lépine JP.

Eur Psychiatry. 2009 Dec;24(8):529-32. doi: 10.1016/j.eurpsy.2009.04.003. Epub 2009 Jun 21.

PMID:
19540729
39.

PDB_REDO: automated re-refinement of X-ray structure models in the PDB.

Joosten RP, Salzemann J, Bloch V, Stockinger H, Berglund AC, Blanchet C, Bongcam-Rudloff E, Combet C, Da Costa AL, Deleage G, Diarena M, Fabbretti R, Fettahi G, Flegel V, Gisel A, Kasam V, Kervinen T, Korpelainen E, Mattila K, Pagni M, Reichstadt M, Breton V, Tickle IJ, Vriend G.

J Appl Crystallogr. 2009 Jun 1;42(Pt 3):376-384. Epub 2009 Apr 3.

40.

HOPE, an open platform for medical data management on the grid.

Diarena M, Nowak S, Boire JY, Bloch V, Donnarieix D, Fessy A, Grenier B, Irrthum B, Legré Y, Maigne L, Salzemann J, Thiam C, Spalinger N, Verhaeghe N, de Vlieger P, Breton V.

Stud Health Technol Inform. 2008;138:34-48.

PMID:
18560106
41.

Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles.

Mégarbane B, Deye N, Bloch V, Sonneville R, Collet C, Launay JM, Baud FJ.

Crit Care. 2007;11(5):R115.

42.

Case report: quantification of methadone-induced respiratory depression using toxicokinetic/toxicodynamic relationships.

Mégarbane B, Declèves X, Bloch V, Bardin C, Chast F, Baud FJ.

Crit Care. 2007;11(1):R5.

43.

Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose.

Mégarbane B, Bloch V, Deye N, Baud FJ.

Intensive Care Med. 2007 Jan;33(1):195-6; author reply 197. Epub 2006 Nov 11. No abstract available.

PMID:
17102961
44.

Extracorporeal life support in a case of acute carbamazepine poisoning with life-threatening refractory myocardial failure.

Mégarbane B, Leprince P, Deye N, Guerrier G, Résière D, Bloch V, Baud FJ.

Intensive Care Med. 2006 Sep;32(9):1409-13. Epub 2006 Jul 12.

PMID:
16835785
45.

Crystal structure of the N-terminal dimerisation domain of VicH, the H-NS-like protein of Vibrio cholerae.

Cerdan R, Bloch V, Yang Y, Bertin P, Dumas C, Rimsky S, Kochoyan M, Arold ST.

J Mol Biol. 2003 Nov 21;334(2):179-85.

PMID:
14607110
46.

The H-NS dimerization domain defines a new fold contributing to DNA recognition.

Bloch V, Yang Y, Margeat E, Chavanieu A, Augé MT, Robert B, Arold S, Rimsky S, Kochoyan M.

Nat Struct Biol. 2003 Mar;10(3):212-8.

PMID:
12592399
47.

RNA recognition by transcriptional antiterminators of the BglG/SacY family: mapping of SacY RNA binding site.

Declerck N, Minh NL, Yang Y, Bloch V, Kochoyan M, Aymerich S.

J Mol Biol. 2002 Jun 21;319(5):1035-48.

PMID:
12079345
48.

Processing of learned information in paradoxical sleep: relevance for memory.

Hennevin E, Hars B, Maho C, Bloch V.

Behav Brain Res. 1995 Jul-Aug;69(1-2):125-35. Review.

PMID:
7546303
49.

Sinus lift as a means of improving restorative options in the edentulous maxilla: a case report.

Bloch VP, Rosenlicht JL.

J N J Dent Assoc. 1993 Spring;64(2):23-5, 27. No abstract available.

PMID:
8410211
50.

Responses of hippocampal cells can be conditioned during paradoxical sleep.

Maho C, Bloch V.

Brain Res. 1992 May 22;581(1):115-22.

PMID:
1498663

Supplemental Content

Support Center